Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2004 3
2005 7
2006 9
2007 5
2008 7
2009 4
2010 9
2011 12
2012 12
2013 11
2014 14
2015 11
2016 13
2017 19
2018 24
2019 28
2020 21
2021 30
2022 16
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P. Wei AH, et al. Among authors: anagnostopoulos a. Blood. 2020 Jun 11;135(24):2137-2145. doi: 10.1182/blood.2020004856. Blood. 2020. PMID: 32219442 Free PMC article. Clinical Trial.
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Adès L, Girshova L, Doronin VA, Díez-Campelo M, Valcárcel D, Kambhampati S, Viniou NA, Woszczyk D, De Paz Arias R, Symeonidis A, Anagnostopoulos A, Munhoz EC, Platzbecker U, Santini V, Fram RJ, Yuan Y, Friedlander S, Faller DV, Sekeres MA. Adès L, et al. Among authors: anagnostopoulos a. Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334. Blood Adv. 2022. PMID: 35728048 Free PMC article. Clinical Trial.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, Nguyen-Khac F, Davis Z, Rigolin GM, Visentin A, Xochelli A, Delgado J, Baran-Marszak F, Stalika E, Abrisqueta P, Durechova K, Papaioannou G, Eclache V, Dimou M, Iliakis T, Collado R, Doubek M, Calasanz MJ, Ruiz-Xiville N, Moreno C, Jarosova M, Leeksma AC, Panayiotidis P, Podgornik H, Cymbalista F, Anagnostopoulos A, Trentin L, Stavroyianni N, Davi F, Ghia P, Kater AP, Cuneo A, Pospisilova S, Espinet B, Athanasiadou A, Oscier D, Haferlach C, Stamatopoulos K; ERIC, the European Research Initiative on CLL. Baliakas P, et al. Among authors: anagnostopoulos a. Blood. 2019 Mar 14;133(11):1205-1216. doi: 10.1182/blood-2018-09-873083. Epub 2019 Jan 2. Blood. 2019. PMID: 30602617 Free PMC article.
ERRATUM.
Tsakou E, Agathagelidis A, Boudjoghra M, Raff T, Dagklis A, Chatzouli M, Smilevska T, Bourikas G, Merle-Beral H, Manioudaki-Kavallieratou E, Anagnostopoulos A, Brüggemann M, Davi F, Stamatopoulos K, Belessi C. Tsakou E, et al. Among authors: anagnostopoulos a. Mol Med. 2014 Jan;19(1):332. doi: 10.2119/molmed.2011.00216.erratum. Epub 2013 Oct 30. Mol Med. 2014. PMID: 24301459 Free PMC article. No abstract available.
Thrombocytopenia in COVID-19: pathophysiology matters.
Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A. Gavriilaki E, et al. Among authors: anagnostopoulos a. Ann Hematol. 2021 Aug;100(8):2139-2140. doi: 10.1007/s00277-020-04183-3. Epub 2020 Jul 18. Ann Hematol. 2021. PMID: 32683455 Free PMC article. No abstract available.
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.
Papadopoulou A, Karavalakis G, Papadopoulou E, Xochelli A, Bousiou Z, Vogiatzoglou A, Papayanni PG, Georgakopoulou A, Giannaki M, Stavridou F, Vallianou I, Kammenou M, Varsamoudi E, Papadimitriou V, Giannaki C, Sileli M, Stergiouda Z, Stefanou G, Kourlaba G, Gounelas G, Triantafyllidou M, Siotou E, Karaglani A, Zotou E, Chatzika G, Boukla A, Papalexandri A, Koutra MG, Apostolou D, Pitsiou G, Morfesis P, Doumas M, Karampatakis T, Kapravelos N, Bitzani M, Theodorakopoulou M, Serasli E, Georgolopoulos G, Sakellari I, Fylaktou A, Tryfon S, Anagnostopoulos A, Yannaki E. Papadopoulou A, et al. Among authors: anagnostopoulos a. Nat Med. 2023 Aug;29(8):2019-2029. doi: 10.1038/s41591-023-02480-8. Epub 2023 Jul 17. Nat Med. 2023. PMID: 37460756 Clinical Trial.
Rituximab-associated immune myelopathy.
Papadaki T, Stamatopoulos K, Anagnostopoulos A, Fassas A. Papadaki T, et al. Among authors: anagnostopoulos a. Blood. 2003 Aug 15;102(4):1557-8. doi: 10.1182/blood-2003-05-1532. Blood. 2003. PMID: 12900357 Free article. No abstract available.
An Update in Drug-Induced Thrombotic Microangiopathy.
Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, Gavriilaki E. Chatzikonstantinou T, et al. Among authors: anagnostopoulos a. Front Med (Lausanne). 2020 May 22;7:212. doi: 10.3389/fmed.2020.00212. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32528969 Free PMC article. No abstract available.
Chronic lymphocytic leukaemia: an immunobiology approach.
Kostareli E, Smilevska T, Stamatopoulos K, Kouvatsi A, Anagnostopoulos A. Kostareli E, et al. Among authors: anagnostopoulos a. Srp Arh Celok Lek. 2008 May-Jun;136(5-6):319-23. doi: 10.2298/sarh0806319k. Srp Arh Celok Lek. 2008. PMID: 18792635 Free article. Review.
219 results